Cite

High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with <scp>Philadelphia‐like</scp> fusions

MLA

Ibrahim Aldoss, et al. “High Response Rates and Transition to Transplant after Novel Targeted and Cellular Therapies in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia with Philadelphia‐like Fusions.” American Journal of Hematology, vol. 98, Mar. 2023, pp. 848–56. EBSCOhost, https://doi.org/10.1002/ajh.26908.



APA

Ibrahim Aldoss, Michelle Afkhami, Dongyun Yang, Zhaohui Gu, Sally Mokhtari, Shilpa Shahani, Hoda Pourhassan, Vaibhav Agrawal, Paul Koller, Shukaib Arslan, Vanina Tomasian, Monzr M. Al Malki, Andrew Artz, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet S. Sandhu, Brian Ball, Salman Otoukesh, … Vinod Pullarkat. (2023). High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia‐like fusions. American Journal of Hematology, 98, 848–856. https://doi.org/10.1002/ajh.26908



Chicago

Ibrahim Aldoss, Michelle Afkhami, Dongyun Yang, Zhaohui Gu, Sally Mokhtari, Shilpa Shahani, Hoda Pourhassan, et al. 2023. “High Response Rates and Transition to Transplant after Novel Targeted and Cellular Therapies in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia with Philadelphia‐like Fusions.” American Journal of Hematology 98 (March): 848–56. doi:10.1002/ajh.26908.